nitrendipine has been researched along with Left Ventricular Hypertrophy in 9 studies
Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the effects of a calcium antagonist (nitrendipine) and an angiotensin converting enzyme inhibitor (enalapril) with those of placebo on left ventricular mass in patients with non-insulin-dependent diabetes mellitus and hypertension." | 9.08 | Effects of nitrendipine and enalapril on left ventricular mass in patients with non-insulin-dependent diabetes mellitus and hypertension. ( Bak, AA; Gerritsen, TA; Grobbee, DE; Jonker, JJ; Stolk, RP, 1998) |
| "To assess the comparative effects of benazepril and nitrendipine monotherapies on left ventricular mass index (LVMI) in hypertensive patients with echocardiographically determined left ventricular hypertrophy, patients with diastolic blood pressure (BP) > or = 100 mm Hg were randomized to benazepril, 10 mg, or nitrendipine, 20 mg, both given once or twice daily." | 9.08 | Benazepril causes in hypertension a greater reduction in left ventricular mass than does nitrendipine: a randomized study using magnetic resonance imaging. ( Bertocchi, F; Campa, PP; Ferri, FM; Gaudio, C; Motolese, M; Tanzilli, G; Villatico Campbell, S, 1998) |
| "Both nitrendipine and captopril have been shown to reverse left ventricular hypertrophy in hypertensive patients." | 9.07 | Nitrendipine vs. captopril in essential hypertension: effects on circadian blood pressure and left ventricular hypertrophy. ( Bachmann, K; Engels, G; Gellert, J; Henneke, KH; Machnig, T; Pongratz, G; Schmalzl, M, 1994) |
| "To evaluate the efficacy and tolerability of nitrendipine in comparison with captopril in hypertensive diabetic patients with left ventricular hypertrophy (LVH)." | 5.08 | Evaluation of the efficacy and tolerability of nitrendipine in reducing both pressure and left ventricular mass in hypertensive type 2 diabetic patients. ( Carraro, A; Crepaldi, G; Fasoli, G; Frigato, F; Marin, M; Nisti, S; Nosadini, R; Palisi, M; Scognamiglio, R; Virgili, F, 1997) |
| "To compare the effects of a calcium antagonist (nitrendipine) and an angiotensin converting enzyme inhibitor (enalapril) with those of placebo on left ventricular mass in patients with non-insulin-dependent diabetes mellitus and hypertension." | 5.08 | Effects of nitrendipine and enalapril on left ventricular mass in patients with non-insulin-dependent diabetes mellitus and hypertension. ( Bak, AA; Gerritsen, TA; Grobbee, DE; Jonker, JJ; Stolk, RP, 1998) |
| "To assess the comparative effects of benazepril and nitrendipine monotherapies on left ventricular mass index (LVMI) in hypertensive patients with echocardiographically determined left ventricular hypertrophy, patients with diastolic blood pressure (BP) > or = 100 mm Hg were randomized to benazepril, 10 mg, or nitrendipine, 20 mg, both given once or twice daily." | 5.08 | Benazepril causes in hypertension a greater reduction in left ventricular mass than does nitrendipine: a randomized study using magnetic resonance imaging. ( Bertocchi, F; Campa, PP; Ferri, FM; Gaudio, C; Motolese, M; Tanzilli, G; Villatico Campbell, S, 1998) |
| "Both nitrendipine and captopril have been shown to reverse left ventricular hypertrophy in hypertensive patients." | 5.07 | Nitrendipine vs. captopril in essential hypertension: effects on circadian blood pressure and left ventricular hypertrophy. ( Bachmann, K; Engels, G; Gellert, J; Henneke, KH; Machnig, T; Pongratz, G; Schmalzl, M, 1994) |
| "Aortic stiffness and left ventricular hypertrophy (LVH) are predictors of mortality in hemodialysis (HD) patients." | 2.71 | Inflammation, arteriosclerosis, and cardiovascular therapy in hemodialysis patients. ( Adda, H; Guerin, AP; London, GM; Marchais, SJ; Metivier, F; Pannier, B, 2003) |
| "Left ventricular hypertrophy is well established as a blood pressure independent cardiovascular risk factor in patients on renal replacement therapy." | 2.68 | Blood pressure independent effects of nitrendipine on cardiac structure in patients after renal transplantation. ( Hauser, I; Neumayer, HH; Rockstroh, JK; Schmieder, RE; Schobel, HP; Vogt-Ladner, G, 1997) |
| "Arterial hypertension is the most common chronic medical condition requiring office visits to physicians and is a major contributing factor to the development of myocardial infarction and stroke." | 2.40 | How should we treat hypertensive women with cardiac and renal impairment? ( Ruilope, LM; Suarez, C, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (88.89) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| London, GM | 1 |
| Marchais, SJ | 1 |
| Guerin, AP | 1 |
| Metivier, F | 1 |
| Adda, H | 1 |
| Pannier, B | 1 |
| Machnig, T | 1 |
| Henneke, KH | 1 |
| Engels, G | 1 |
| Pongratz, G | 1 |
| Schmalzl, M | 1 |
| Gellert, J | 1 |
| Bachmann, K | 1 |
| Zhao, LY | 1 |
| Cao, SP | 1 |
| Rockstroh, JK | 1 |
| Schobel, HP | 1 |
| Vogt-Ladner, G | 1 |
| Hauser, I | 1 |
| Neumayer, HH | 1 |
| Schmieder, RE | 1 |
| Scognamiglio, R | 1 |
| Nosadini, R | 1 |
| Marin, M | 1 |
| Nisti, S | 1 |
| Fasoli, G | 1 |
| Palisi, M | 1 |
| Frigato, F | 1 |
| Virgili, F | 1 |
| Carraro, A | 1 |
| Crepaldi, G | 1 |
| Kribben, A | 1 |
| Anlauf, M | 1 |
| Distler, A | 1 |
| Gärtner, H | 1 |
| Holzgreve, H | 1 |
| Michaelis, J | 1 |
| Röcker, L | 1 |
| Schäfers, R | 1 |
| Philipp, U | 1 |
| Wellek, S | 1 |
| Philipp, T | 1 |
| Ruilope, LM | 1 |
| Suarez, C | 1 |
| Gerritsen, TA | 1 |
| Bak, AA | 1 |
| Stolk, RP | 1 |
| Jonker, JJ | 1 |
| Grobbee, DE | 1 |
| Gaudio, C | 1 |
| Tanzilli, G | 1 |
| Ferri, FM | 1 |
| Villatico Campbell, S | 1 |
| Bertocchi, F | 1 |
| Motolese, M | 1 |
| Campa, PP | 1 |
1 review available for nitrendipine and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
How should we treat hypertensive women with cardiac and renal impairment?
Topics: Adrenergic beta-Antagonists; Aged; Albuminuria; Antihypertensive Agents; Blood Pressure; Diuretics; | 1997 |
7 trials available for nitrendipine and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Inflammation, arteriosclerosis, and cardiovascular therapy in hemodialysis patients.
Topics: Adult; Antihypertensive Agents; Aortic Diseases; Arteriosclerosis; Atenolol; Blood Pressure; C-React | 2003 |
Nitrendipine vs. captopril in essential hypertension: effects on circadian blood pressure and left ventricular hypertrophy.
Topics: Blood Pressure; Blood Pressure Monitoring, Ambulatory; Captopril; Circadian Rhythm; Drug Combination | 1994 |
Blood pressure independent effects of nitrendipine on cardiac structure in patients after renal transplantation.
Topics: Adult; Aged; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Female; Heart; Humans; H | 1997 |
Evaluation of the efficacy and tolerability of nitrendipine in reducing both pressure and left ventricular mass in hypertensive type 2 diabetic patients.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Calcium Channe | 1997 |
Hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment. Influence on LVH, proteinuria and metabolic parameters. The HANE Trial Research Group.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Ant | 1997 |
Effects of nitrendipine and enalapril on left ventricular mass in patients with non-insulin-dependent diabetes mellitus and hypertension.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Enala | 1998 |
Benazepril causes in hypertension a greater reduction in left ventricular mass than does nitrendipine: a randomized study using magnetic resonance imaging.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Blood Pressure; Calcium Channel | 1998 |
1 other study available for nitrendipine and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
[The changes in plasma arginine-vasopressin in patients with essential hypertension and the correlation with patient's condition].
Topics: Adult; Aged; Arginine Vasopressin; Female; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ve | 1993 |